EMA publishes QPPV Update
In April 2016 the European Medicines Agency (EMA) published the first issue of the quarterly issued "QPPV Update - What´s new in Pharmacovigilance". The "QPPV Update" replaces the "Pharmacovigilance Programme Update" which focused on information systems and services.
The new newsletter contains general information regarding pharmacovigilance and provides Qualified Persons responsible for Pharmacovigilance (QPPVs) and all other people working in pharmacovigilance with an update on EU pharmacovigilance.
The first issue of the "QPPV Update" covers the following topics:
- Pharmacovigilance in the product lifecycle,
- Pharmacovigilance processes,
- Pharmacovigilance guidance,
- Pharmacovigilance IT systems,
- Pharmacovigilance dialogue.
Qualified Persons for Pharmacovigilance (QPPVs) who are registered in the XEVMPD database according to Article 57 of Regulation (EG) No 726/2004 receive this document directly via EudraLink. You can find the Newsletter on the website of the EMA.
Related GMP News
16.04.2025EMA: Revised IRIS Documents
09.04.2025Centralised Procedures: Q&As Updated
12.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications